Sunday 18 October 2026
Export ARMP’s income statement to Excel — free account
Armata Pharmaceuticals, Inc.
ARMP Healthcare Biotechnology
Armata Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.9 million, down 5.22% from fiscal 2024. In the quarter to June 2026, revenue grew 15.7%, EPS grew 548.9%, free cash flow fell 18.0% and total debt rose 152.4%, each against the same quarter a year earlier.
3.37
0.28
+9.06%
Follow ARMP
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 127.83% | 154.70% | 130.37% | 64.00% |
+8 more TTM periods Free account |
|
Piotroski F-Score |
— | 3 | 2 | 1 | |
| (225.11%) | (359.90%) | (212.83%) | (49.96%) | ||
ROIC |
(89.61%) | (87.61%) | (77.26%) | (57.94%) | |
Return on Tangible Assets |
90.73% | (3,325.65%) | (1,249.00%) | 42.46% | |
Average Days of Receivables |
166.73 | 3.30 | 35.13 | 54.82 | |
Free Cash Flow per Share |
(0.70) | (0.67) | (0.73) | (0.76) | |
Free Cash Flow |
(25.79) | (24.47) | (26.30) | (27.43) | |
Capital Expenditures |
(0.37) | (0.51) | (0.54) | (0.41) | |
| Other line items | |||||
Cash ROIC |
(33.81%) | (67.85%) | (55.95%) | (41.88%) | |
Accounts Receivable Turnover |
2.36 | 36.51 | 8.07 | 3.39 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
461.68% | 469.03% | 483.63% | 516.36% | |
Selling, General and Administrative Expense of Revenue |
274.87% | 242.58% | 253.04% | 243.49% | |
Share Based Compensation of Revenue |
103.19% | 55.82% | 53.22% | 46.14% | |
Interest Coverage |
(1.90) | (2.01) | (2.21) | (2.22) | |
Operating CF/Net income |
0.13 | 0.08 | 0.15 | 0.58 | |
Depreciation/Fixed assets |
0.16 | 0.14 | 0.13 | 0.12 | |
Capex/Depreciation |
(0.20) | (0.31) | (0.35) | (0.28) | |
Revenue per Share |
0.15 | 0.14 | 0.14 | 0.14 | |
Operating CF per Share |
(0.69) | (0.66) | (0.71) | (0.75) | |
Capex per Share |
(0.01) | (0.01) | (0.01) | (0.01) | |
Capex to Sales |
0.07 | 0.10 | 0.11 | 0.08 |
Columns are period end dates